Status:
WITHDRAWN
Naloxone Methadone Combination (NAMEKO)
Lead Sponsor:
Kuopio University Hospital
Conditions:
Opiate Dependence
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of the study is to examine the tolerability and abuse potential of the diluted methadone solution (5 mg/ml → 2 mg/ml) in combination with naloxone in opioid substitution treatment. Study hypo...
Eligibility Criteria
Inclusion
- opioid dependence
- methadone treatment
- no changes in methadone dose during the last 10 days
- good treatment compliance according to doctor
- normal ALAT and AFOS values (increased if double the normal level)
Exclusion
- severe renal or hepatic failure
- acute psychosis
- age under 18
- pregnancy
- legal incompetence
- severe somatic disease
- chaotic situation in life
- medication or disease which is contraindication to study treatment
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01160432
Start Date
May 1 2013
End Date
July 1 2013
Last Update
July 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kuopio University Hospital
Kuopio, Finland, 70211